Diagnosis Evaluation And Research Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 12-12-2024
- Paid Up Capital ₹ 2.50 M
as on 12-12-2024
- Company Age 20 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.82 Cr
as on 12-12-2024
- Satisfied Charges ₹ 2.68 Cr
as on 12-12-2024
- Revenue 3.72%
(FY 2019)
- Profit -2.64%
(FY 2019)
- Ebitda 11.66%
(FY 2019)
- Net Worth -6.86%
(FY 2019)
- Total Assets -6.13%
(FY 2019)
About Diagnosis Evaluation And Research
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹2.82 Cr. The company has closed loans amounting to ₹2.68 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jassim Abdulla, Shabana Basheer, Bilavinakath Jasmine, and One other member serve as directors at the Company.
- CIN/LLPIN
U85195KL2004PTC017066
- Company No.
017066
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Apr 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Kannur, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Diagnosis Evaluation And Research?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jassim Abdulla  | Managing Director | 26-Apr-2004 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shabana Basheer | Director | 26-Apr-2004 | Current |
| Bilavinakath Jasmine | Director | 26-Apr-2004 | Current |
| Abdulla Zubair | Director | 26-Apr-2004 | Current |
Financial Performance and Corporate Structure Insights of Diagnosis Evaluation And Research.
Diagnosis Evaluation And Research Private Limited, for the financial year ended 2019, experienced modest growth in revenue, with a 3.72% increase. The company also saw a slight decrease in profitability, with a 2.64% decrease in profit. The company's net worth dipped by a decrease of 6.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Diagnosis Evaluation And Research?
In 2017, Diagnosis Evaluation And Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Real Forts And Resorts Pvt LtdActive 31 years 3 monthsBilavinakath Jasmine and Abdulla Zubair are mutual person
- Pointec Writing Instruments Private LimitedActive 29 years 7 months
Abdulla Zubair is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 Dec 2023 | ₹5.00 M | Open |
Union Bank Of India Creation Date: 28 Feb 2014 | ₹2.50 M | Open |
Union Bank Of India Creation Date: 30 Dec 2009 | ₹2.07 Cr | Open |
How Many Employees Work at Diagnosis Evaluation And Research?
Diagnosis Evaluation And Research has a workforce of 1 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Diagnosis Evaluation And Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Diagnosis Evaluation And Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
